|
Volumn 27, Issue 1, 2015, Pages 1-3
|
Common TLR5mutations control cancer progression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
GALECTIN 1;
INTERLEUKIN 17;
INTERLEUKIN 6;
K RAS PROTEIN;
TOLL LIKE RECEPTOR 5;
ADOPTIVE TRANSFER;
ARTICLE;
BONE MARROW CELL;
BREAST CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER GROWTH;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CANCER SURVIVAL;
COMMENSAL;
DEPLETION;
GAMMA DELTA T LYMPHOCYTE;
GENE MUTATION;
HUMAN;
IMMUNOMODULATION;
INFLAMMATION;
INTESTINE FLORA;
LOSS OF FUNCTION MUTATION;
NONHUMAN;
OVARY CANCER;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
SARCOMA;
ANIMAL;
GENETICS;
IMMUNOLOGY;
METABOLISM;
MICROFLORA;
NEOPLASM;
PATHOLOGY;
ANIMALS;
HUMANS;
INTERLEUKIN-17;
INTERLEUKIN-6;
MICROBIOTA;
NEOPLASMS;
TOLL-LIKE RECEPTOR 5;
|
EID: 84922138085
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccell.2014.12.008 Document Type: Short Survey |
Times cited : (18)
|
References (10)
|